Evidence map›Paper›PMID 28713655›Full record

ArticlePeerJ2017

Differential effect of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) on leukocyte infiltration during contact hypersensitivity responses.

Merideth Early, William G Schroeder, Ranajana Unnithan, John M Gilchrist, William A Muller, Alan Schenkel

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer's disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
  3. Article
  4. Strategies for Mast Cell Inhibition in Food Allergy.The Yale journal of biology and medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Merideth Early *Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, United States of America.
William G Schroeder *Department of Pediatrics, University of Colorado Health Sciences Center, Aurora, CO, United States of America.
Ranajana UnnithanDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, United States of America.
John M GilchristDepartment of Physiology, University of California, San Francisco, United States of America.
William A MullerDepartment of Pathology, Northwestern University, Chicago, IL, United States of America.
Alan SchenkelDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, United States of America.
Colorado State University · USNorthwestern University · USUniversity of California, San Francisco · USUniversity of Colorado Health · US

Funding

TWO NOVEL VASCULAR ADHESION MOLECULES: PECAM AND HEC-1R01HL046849 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MULLER, WILLIAM A · 1991 to 2019
$6.7M
Beyond PECAM: Mechanisms of Transendothelial MigrationR37HL064774 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MULLER, WILLIAM A · 2005 to 2014
$4.0M
PECAM-INDEPENDENT TRANSENDOTHELIAL MIGRATIONR01HL064774 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI MULLER, WILLIAM A · 2000 to 2020
$3.3M
NHLBI NIH HHS R01 HL046849NHLBI NIH HHS R01 HL064774NHLBI NIH HHS R37 HL064774
6 · The paper itself

Abstract

background2'-4' Dinitrofluorobenzene (DNFB) induced contact hypersensitivity is an established model of contact sensitivity and leukocyte migration. Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) deficient mice were used to examine the role of PECAM-1 in the migration capacity of several different leukocyte populations after primary and secondary application.

resultsγδ T lymphocytes, granulocytes, and Natural Killer cells were most affected by PECAM-1 deficiency at the primary site of application. γδ T lymphocytes, granulocytes, DX5+ Natural Killer cells, and, interestingly, effector CD4+ T lymphocytes were most affected by the loss of PECAM-1 at the secondary site of application.

conclusionsPECAM-1 is used by many leukocyte populations for migration, but there are clearly differential effects on the usage by each subset. Further, the overall kinetics of each population varied between primary and secondary application, with large relative increases in γδ T lymphocytes during the secondary response.

Indexed as

CD4+ T lymphocytesContact HypersensitivityEmigrationGranulocytesLeukocyteMonocytesNatural Killer LymphocytesPlatelet Endothelial Cell Adhesion Molecule-1γδT lymphocytes

Identifiers

PMID28713655
PMCPMC5507171
OpenAlexW2611668108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.